Trending...
- Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 236
- Move in this Fall! New Released Quick Move-In Townhomes at Heritage at South Brunswick with Limited-Time Incentives
- synseer Nominated for Best Startup in 2026 Prix Galien USA Awards Following Record Breaking Applicant Pool
TEMECULA, Calif. - Floridant -- NATCO proudly announces that the United States Patent and Trademark Office (USPTO) has officially granted U.S. Patent No. 12,453,363 B2 for its latest invention, Persimonal®, a proprietary technology for preparing persimmon leaf extract.
This milestone patent underscores NATCO's commitment to advancing botanical science and delivering innovative, clinically relevant solutions in natural health and nutrition. Persimonal® represents a novel approach to harnessing the bioactive compounds of persimmon leaves, long valued in traditional medicine for their antioxidant, anti-inflammatory, and cardiovascular-supportive properties.
Key Highlights of Persimonal®
Executive Statement
More on The Floridant
"The awarding of this U.S. patent validates NATCO's dedication to scientific excellence and innovation in natural product development," said [Abdul Alkayali], [Executive Vice President] at NATCO. "Persimonal® is more than an extraction method—it's a platform for unlocking the full potential of persimmon leaves to support human health."
About NATCO
NATCO is a leader in natural product innovation, specializing in proprietary technologies that transform traditional botanicals into clinically relevant, market-ready solutions. With a focus on science, sustainability, and consumer wellness, NATCO continues to pioneer advancements that set new standards in the nutraceutical industry.
www.natcohealthyliving.com
This milestone patent underscores NATCO's commitment to advancing botanical science and delivering innovative, clinically relevant solutions in natural health and nutrition. Persimonal® represents a novel approach to harnessing the bioactive compounds of persimmon leaves, long valued in traditional medicine for their antioxidant, anti-inflammatory, and cardiovascular-supportive properties.
Key Highlights of Persimonal®
- Patent Protection: U.S. Patent No. 12,453,363 B2 secures NATCO's proprietary process for preparing persimmon leaf extract.
- Scientific Innovation: Persimonal® optimizes extraction to preserve and enhance the potency of polyphenols, flavonoids, and other beneficial compounds.
- Health Potential: Persimmon leaf extract has been studied for supporting vascular health, lowering blood pressure and cholesterol, metabolic balance, and overall wellness.
- Market Differentiation: Persimonal® positions NATCO at the forefront of botanical innovation, offering a unique, patent-backed ingredient for nutraceutical and functional food applications.
Executive Statement
More on The Floridant
- Final Call: Free 3-Day AI for Business Summit Starts This Week, Registration Closing
- BankAtlas Introduces Proprietary U.S. Bank Equity Index Family
- BlazeHive's AI SEO Agent Outranks Human Writers on 500+ Google Top-3 Results in 5 Months, on Autopilot
- OLENPHOGY Addresses the Berberine Dosage Paradox to Reduce GI Distress
- OLENPHOGY Exposes the "Missing Link" in Standard 40:1 Inositol Formulations
"The awarding of this U.S. patent validates NATCO's dedication to scientific excellence and innovation in natural product development," said [Abdul Alkayali], [Executive Vice President] at NATCO. "Persimonal® is more than an extraction method—it's a platform for unlocking the full potential of persimmon leaves to support human health."
About NATCO
NATCO is a leader in natural product innovation, specializing in proprietary technologies that transform traditional botanicals into clinically relevant, market-ready solutions. With a focus on science, sustainability, and consumer wellness, NATCO continues to pioneer advancements that set new standards in the nutraceutical industry.
www.natcohealthyliving.com
Source: NATCO, Inc
Filed Under: Health
0 Comments
Latest on The Floridant
- Phinge & CEO Robert DeMaio Publicly Declare Cash Settlements or Judgments Alone Cannot & Will Not Remedy the Deep Public Harm of Infringing Its IP
- Dana Flanagan Expands the Authority Architect, Bringing a Nontraditional Approach to Executive Authority, Strategic Access and Business Growth
- Phinge's Netverse: Reclaiming the Digital Frontier For Everyone Through CEO Robert DeMaio's Vision of a True App-less, User Data Sovereign World
- DuraFast Label Company Launches Seiko SLP850 2" Thermal Printer with Free Label Promotion
- Institutional Trust Collapses as Americans Question Authority, COVID Disclosures, Societal Rules
- Scientific Figure Releases Free Layout Template Libraries for Graphical Abstracts and Research Posters
- Vendor Space Still Available for the Mid Florida Car Show & Auto Swap Meet, September 19–20
- Permian Museum announces the addition of an Ancient Alien Artifacts photo gallery
- Can You End a Rental lease before it expires in Michigan?
- Sizzle Dining turns 10 — and it's going bigger than ever
- Priority Marketing earns 11 honors at FPRA's 2026 Golden Image and Pinnacle Awards
- Nova Classical STEM Academy welcomes first students of inaugural school year
- Millennium Physician Group and Franciscan Alliance announce strategic partnership
- Gulf Coast Humane Society hosts Back-to-School Community Fair on Aug. 29
- The Golden Jazz Fest Shuttle Returns for 2026
- KeysCaribbean Resorts Offer Savings On Vacations Through Aug. 31, Preview Exceptional Select Fall Rates of Less Than $200/Night
- Fit Body Boot Camp Launches Nationwide 'Fit Body Forever' Workshops to Help Adults 60+ Rebuild Strength and Prevent Falls
- Honeyfund Marks 20 Years With Real Honeymoons Contest
- Canadian Aerospace Defence Talent Expo (CADTE) Launches National TalentThread Initiative to Strengthen Canada's Future Workforce
- Bay Street Yard to host college and NFL football watch parties this season
